Kinome focused CRISPR-Cas9 screens in African ancestry patient-derived breast cancer organoids identifies essential kinases and synergy of EGFR and FGFR1 inhibition

Florencia P. Madorsky Rowdo(Cornell University), M. Laura Martín(Cornell University)
bioRxiv (Cold Spring Harbor Laboratory)
December 12, 2023
10.1101/2023.12.11.570465
Cited by 2

Related Papers

Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long‑term BRAF inhibition
|International Journal of Oncology|2020|29
Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition
|Cancer Research|2025|12
In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells
|Oncology Reports|2017|7
Kinome focused CRISPR-Cas9 screens in African ancestry patient-derived breast cancer organoids identify essential kinases and synergy of EGFR and FGFR1 inhibition
|Research Square|2024|1